Aquestive Therapeutics (AQST) Total Non-Current Liabilities (2017 - 2026)
Aquestive Therapeutics (AQST) recorded Total Non-Current Liabilities of $182.51 million in Q2 2026, up 11.1% from $164.24 million a year earlier and up 7.9% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
At the end of FY2025, Aquestive Therapeutics reported Total Non-Current Liabilities of $186.82 million, up 17.4% from FY2024.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $159.19 million in FY2024 (-1.7%), $161.89 million in FY2023 (-6.7%), $173.59 million in FY2022 (+22.6%) and $141.64 million in FY2021 (+29.4%).
- Quarterly Total Non-Current Liabilities has ranged from $123.83 million in Q3 2021 to $186.82 million in Q4 2025 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities has increased for five consecutive quarters, with growth averaging 5.3% over the last eight quarters.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 44.9% in Q3 2021, against a decline of 6.7% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $169.13 million (Q1 2026), $186.82 million (Q4 2025) and $165.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Aquestive Therapeutics | 581.12 Mn | 121.66 Mn | 9.80 Mn | 182.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 182.51 Mn |
| Mar 31, 2026 | 169.13 Mn |
| Dec 31, 2025 | 186.82 Mn |
| Sep 30, 2025 | 165.61 Mn |
| Jun 30, 2025 | 164.24 Mn |
| Mar 31, 2025 | 160.95 Mn |
| Dec 31, 2024 | 159.19 Mn |
| Sep 30, 2024 | 153.35 Mn |
| Jun 30, 2024 | 151.06 Mn |
| Mar 31, 2024 | 163.80 Mn |
| Dec 31, 2023 | 161.89 Mn |
| Sep 30, 2023 | 160.36 Mn |
| Jun 30, 2023 | 161.64 Mn |
| Mar 31, 2023 | 168.46 Mn |
| Dec 31, 2022 | 173.59 Mn |
| Sep 30, 2022 | 157.51 Mn |
| Jun 30, 2022 | 150.29 Mn |
| Mar 31, 2022 | 147.81 Mn |
| Dec 31, 2021 | 141.64 Mn |
| Sep 30, 2021 | 123.83 Mn |
API Access
Aquestive Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();